RESUMOO Câncer de Próstata é o mais prevalente entre os homens no Brasil, atrás apenas do câncer de pele não melanoma; e o segundo em relação a mortalidade. Portanto, conhecer a doença, suas manifestações clínicas, seus fatores de risco e como é conduzido e feito seu diagnóstico é de extrema importância para a prática clínica. No presente trabalho, foi realizada uma revisão atual sobre a doença com ênfase em seu diagnóstico.
Objective: To provide a tool to assist health professionals in the medical clinic regarding treatments still under study to combat COVID-19 and serve as a basis for future studies. Methods: For the development of this systematic review, research was carried out on the Embase, Pubmed databases and on the website clinicaltrials.gov, with the following inclusion criteria: selection of clinical trials carried out in adults, randomized or not, who addressed the discussion on the treatment or development of vaccines for COVID-19. Of the articles found, 22 studies were selected and those with a different methodological design were excluded. Results: The studies cover clinical trials that are divided into double or triple blind and present a low risk of bias. Among the tested interventions, Hydroxychloroquine and antivirals are the drugs that show the most promise in controlling the disease. The final results, however, are not yet available, as studies are ongoing. Final considerations: There is still no scientific evidence to recommend the use of any of the tested drugs, making it necessary to continue and maintain ongoing studies.
Tuberculose pulmonar e os desafios do tratamento em paciente em situação de rua: relato de caso Pulmonary tuberculosis and the challenges of treating a homeless patient: a case report
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.